mivac

MIVAC Development is a biopharmaceutical company focused on development and commercialization of novel treatments of autoimmune diseases and mucosal vaccine development. The projects are developed from basic research to commercially viable projects that can be either spun out as separate companies, co-developed with external parties or out-licensed.


Portfolio companies:

  • Toleranzia - developing revolutionary tolerance-inducing treatments with the potential to cure autoimmune diseases.
    Read more

  • Alzinova - develops innovative therapeutics for Alzheimer's disease treatment.
    Read more

MIVAC Development is continuously open to opportunities to expand its research portfolio by licensing new ideas within our research fields. For enquires, please contact us.

 
company_puff research_puff